Clinical Trials

Study Title:
A Phase 1b Dose Escalation Study of AV-380 in Combination with Chemotherapy or Immunotherapy in Cancer Patients with Elevated GDF-15 Levels Colorectal Cancer, NSCLC, Pancreatic Cancer

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Toros Dincman, at dincmant@musc.edu. Study Coordinator, Carly Fecio, at fecio@musc.edu. Trial opened at the following institutions: Medical University of South Carolina